August 2026

Imricor Medical Systems and Philips have launched a combined interventional MR lab solution integrating Philips’ 1.5T BlueSeal MRI with Imricor’s MR-compatible systems, targeting cardiac electrophysiology and setting a new standard for MR-guided interventions.

Sea Forest Limited (ASX:SEA) reported a spectacular 486% surge in SeaFeed revenue for FY26, underpinned by 131,000 cattle committed, surpassing breakeven targets, and a robust $27.8 million cash buffer. The company advances its commercial footprint domestically and internationally, with carbon credit revenue set to kick off in late 2027.

Patrys has cleared a key regulatory hurdle with Human Research Ethics Committee approval for its Phase 1A clinical trial of RLS-2202, aiming to start dosing healthy volunteers this quarter.

West Cobar Metals is broadening its scandium exploration at Salazar by adding the Benriach Prospect to its Q4 2026 air-core drilling program, aiming to tap near-surface scandium enrichment and higher-grade zones within its existing resource.

Percheron Therapeutics has partnered with Vanderbilt Health to initiate a clinical trial testing HMBD-002 in combination with standard treatments for high-risk acute myeloid leukaemia and myelodysplastic syndrome, targeting a recruitment start in late 2026.

Virgin Australia Holdings (ASX:VGN) posted a 13.4% rise in underlying EBIT to $753 million for FY26, declaring a fully franked dividend of 7.6 cents per share, its first since relisting. The airline’s transformation program, fleet renewal, and operational resilience underpin its improved financial and customer metrics.

Weebit Nano surged to record revenue of $15.3 million in FY26, fueled by key licensing deals and product tape-outs, while investing heavily in R&D and AI initiatives. Despite a $54.9 million loss, a $102 million capital raise leaves the company well-positioned for growth.

Talius Group’s HY2026 results reveal a strategic pivot towards higher-margin software subscriptions, with gross margin surging to 51% despite a 19% revenue dip due to hardware deployment timing. Active subscriptions topped 53,200, underpinning a $3.26 million ARR, while cash burn shrank dramatically.

NobleOak Life delivered robust FY26 results with in-force premiums climbing 18% to $549.2 million and underlying NPAT up 15%, driven by strong market share gains and operational efficiency.

Zimplats Holdings reported a strong FY2026 with revenue climbing 57% to US$1.3 billion and profit before tax soaring 484% to US$387.5 million, driven by higher metal prices, increased ore volumes, and improved operational efficiency.

LTR Pharma is shifting gears from clinical trials to commercial rollout, securing US partnerships for ROXUS and reporting encouraging SPONTAN Phase II data that supports FDA approval ambitions.

St Barbara Limited's FY26 statutory profit surged to A$490 million, driven by a A$500 million gain from deconsolidating New Simberi Gold after Lingbao's strategic investment. The company declared a fully franked dividend and is weighing a significant share buy-back while advancing key gold projects.

Swift TV Ltd advanced its commercial rollout with 7,190 devices sold and secured key technology certifications in FY26, while navigating a 22% revenue decline due to legacy contract wind-downs. The company delivered positive EBITDA and raised $2.3 million to fund growth initiatives.

Shine Justice Ltd reported a modest 2.3% revenue increase to $209.2 million for FY26, alongside a striking 1,578% jump in net profit after tax to $9.6 million. The company declared a fully franked final dividend of 2.5 cents per share, signalling confidence amid ongoing investments in technology and international expansion.

Elevra Lithium posted a $44 million profit in FY26 after merging Sayona Mining and Piedmont Lithium, overcoming temporary mining challenges and securing full funding for the North American Lithium expansion.

Civmec delivered a robust FY26 with 11.4% revenue growth and a 22.5% jump in net profit, underpinned by a diversified project pipeline and strategic defence expansion.

Julian Cook has resigned as an executive director of Winton Land, citing fundamental disagreements with the majority shareholder on board roles and governance, following similar departures by other directors.

Air New Zealand reported a $242 million net loss for FY2026, hit by soaring fuel prices and multi-year engine issues despite revenue growth and operational gains.

McMillan Shakespeare (ASX:MMS) reported a 13.8% rise in underlying net profit after tax and amortisation to $107.9 million for FY26, driven by strong novated lease growth and accelerating electric vehicle adoption.

Echelon Resources (ASX:ECH) reported a 341% jump in net profit to A$28.2 million for FY26, driven by stronger gas prices and a A$12.1 million gain from its exit of Cue Energy. The group also repaid A$37 million of debt, leaving it well positioned for upcoming gas drilling at Palm Valley.

Sky Network Television Limited posted a robust FY26 with 9% revenue growth, a 45% dividend increase, and secured major sports rights through 2034, underpinned by the integration of Sky Free.

Hallenstein Glasson delivered a robust FY26 performance with group sales climbing 19.6% to $563 million and net profit before tax surging around 43.5%, buoyed by currency tailwinds and solid operational control.

Rua Bioscience's FY26 results highlight a 71% surge in customer revenue driven by international expansion, yet the company continues to face significant losses and going concern risks.

Locate Technologies (NZX: LOC) posted a NZD 3.53 million loss for FY2026 despite 7.8% revenue growth, facing refinancing uncertainty on a major debt facility due in November.